Risk of Injection-Site Abscess among Infants Receiving a Preservative-Free, Two-Dose Vial Formulation of Pneumococcal Conjugate Vaccine in Kenya.

Risk of Injection-Site Abscess among Infants Receiving a Preservative-Free, Two-Dose Vial Formulation of Pneumococcal Conjugate Vaccine in Kenya.

There is a theoretical risk of adverse events following immunization with a preservative-free, 2-dose vial formulation of 10-valent-pneumococcal conjugate vaccine (PCV10). We set out to measure this risk. Four population-based surveillance sites in Kenya (total annual birth cohort of 11,500 infants)...

Full description

Bibliographic Details
Main Authors: Deron C Burton, Godfrey M Bigogo, Allan O Audi, John Williamson, Kenneth Munge, Jackline Wafula, Dominic Ouma, Sammy Khagayi, Isaac Mugoya, James Mburu, Shadrack Muema, Evasius Bauni, Tahreni Bwanaali, Daniel R Feikin, Peter M Ochieng, Ondari D Mogeni, George A Otieno, Beatrice Olack, Tatu Kamau, Melissa K Van Dyke, Robert Chen, Paddy Farrington, Joel M Montgomery, Robert F Breiman, J Anthony G Scott, Kayla F Laserson
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4625023?pdf=render

Internet

http://europepmc.org/articles/PMC4625023?pdf=render

Similar Items